business

Drugs Giant AstraZeneca Reveals Higher Profits, Savings Plan

Drugs Giant AstraZeneca Reveals Higher Profits, Savings Plan

Following the updates, AstraZeneca’s share price jumped 3.1 percent on the London stock exchange, where the benchmark FTSE 100 index was up slightly overall. Alongside its blockbuster cancer drugs, AstraZeneca has also been developing a weight-loss treatment, given the popularity of GLP-1 drugs such as Novo Nordisk’s Wegovy and Eli Lilly’s Mounjaro.

British pharmaceutical group AstraZeneca announced Friday a 23-percent jump in net profit for the third quarter and a new programme aiming for annual savings of $1.5 billion.

Profit after tax increased to $3.12 billion in the July-September period compared with the third quarter of last year thanks in large part to its cancer treatments, Britain’s biggest drugs company said in a statement.

Welcoming also a rise in revenue, chief executive Pascal Soriot said AstraZeneca had “multiple potential blockbuster” drugs in late-stage development.

Its savings programme will cost $2.0 billion before delivering the desired yearly benefits.

“AstraZeneca is in a catalyst-rich period with more than 180 pipeline projects driving its next wave of growth and scientific innovation,” the company said.

“To capitalise on this opportunity, the company has initiated the Reshaping for Sustainable Growth programme to… invest behind its industry-leading pipeline and transformative technologies.”

AstraZeneca said the savings generated would be reinvested into the drugs pipeline.

Group revenue grew seven percent to $16.2 billion in the third quarter from a year earlier, with oncology accounting for 48 percent of the total.

The company said it remained on track to meet a 2030 target of $80 billion in group annual revenue, up from nearly $59 billion last year.

It predicts sales in the United States to account for half of the target.

Increasingly pivoting to the US market, AstraZeneca in February began listing its shares directly on the New York Stock Exchange to attract more investors.

The group added Friday that net profit reached $8.7 billion for the first nine months of the year.

Following the updates, AstraZeneca’s share price jumped 3.1 percent on the London stock exchange, where the benchmark FTSE 100 index was up slightly overall.

The group is also increasing its focus on China and earlier this year said it would invest $15 billion in the country by 2030 to expand manufacturing and research.

Alongside its blockbuster cancer drugs, AstraZeneca has also been developing a weight-loss treatment, given the popularity of GLP-1 drugs such as Novo Nordisk’s Wegovy and Eli Lilly’s Mounjaro.

  • astrazeneca
  • group
  • drug
  • savings
  • percent
  • company
  • profit
  • quarter

Summaries and tags are generated automatically. Stay informed with VidiaNews.

Related news

Photos: MTN Ghana marks 30 years of service with stakeholder dinner
business

Photos: MTN Ghana marks 30 years of service with stakeholder dinner

Telecommunications giant MTN Ghana has marked its 30th anniversary with a stakeholder dinner in Accra, celebrating three decades of connecting people, businesses and communities and contributing to Ghana’s digital and socio-economic development. Also present were MTN Group Board Chairman, Mcebisi Jonas; MTN Group President and CEO, Ralph Mupita; members of the Group Executive Committee; the Chairman of the MTN Ghana Board, Ishmael Yamson; and MTN Ghana CEO, Stephen Blewett.

Read →
Twifo Hemang residents demand ECG action over high electricity bills
business

Twifo Hemang residents demand ECG action over high electricity bills

Residents of Twifo Hemang in the Central Region have called on the Electricity Company of Ghana (ECG) to address concerns over high electricity bills, discrepancies in meter details and difficulties accessing customer support. Another resident, Yaw Frimpong, said the existing ECG office at Twifo Praso was inadequate to serve consumers in Twifo Hemang and surrounding communities.

Read →
Cornerstone Insurance appoints company secretary
business

Cornerstone Insurance appoints company secretary

“Ms Oyeneyin succeeds the Company’s erstwhile Company Secretary - PAC Solicitors. The Board thanks PAC Solicitors for their support and professional conduct during their tenure of service to the Company,” the insurance company said.

Read →